Professor | Fei Li | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Fei Li
Contact Information	nli_fei@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Fei Li

Contact Information

nli_fei@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2009.9-2015.7 PhD: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences 2005.9-2009.7 Bachelor: School of Life Sciences, Northeast Normal University 2022 National Overseas High-Level Talent Program (Youth) 2021 Shanghai Overseas High-Level Talent Program 2021 Distinguished Professor of Shanghai Universities (Oriental Scholar)
Work Experience	2021.5-present - Fudan University - Young Researcher, Doctoral Supervisor 2017.8-2021.3 - Perlmutter Cancer Center, New York University Medical Center - Postdoctoral Researcher 2016.3-2017.7 - Dana-Farber Cancer Institute, Harvard Medical School - Postdoctoral Researcher 2015.7-2016.3 - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences - Assistant Researcher
Awards	2022: Excellent Award at the Oriental Forum 2015: Outstanding Graduate of Beijing Universities 2015: Outstanding Graduate of the University of Chinese Academy of Sciences 2014: National Scholarship 2014: Model Student of the University of Chinese Academy of Sciences 2014: Wang Yinglai Scholarship 2012: Pfizer Scholarship 2009: Outstanding Graduate of Northeast Normal University

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2009.9-2015.7 PhD: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
2005.9-2009.7 Bachelor: School of Life Sciences, Northeast Normal University
2022 National Overseas High-Level Talent Program (Youth)
2021 Shanghai Overseas High-Level Talent Program
2021 Distinguished Professor of Shanghai Universities (Oriental Scholar)

Work Experience

2021.5-present - Fudan University - Young Researcher, Doctoral Supervisor
2017.8-2021.3 - Perlmutter Cancer Center, New York University Medical Center - Postdoctoral Researcher
2016.3-2017.7 - Dana-Farber Cancer Institute, Harvard Medical School - Postdoctoral Researcher
2015.7-2016.3 - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences - Assistant Researcher

Awards

2022: Excellent Award at the Oriental Forum
2015: Outstanding Graduate of Beijing Universities
2015: Outstanding Graduate of the University of Chinese Academy of Sciences
2014: National Scholarship
2014: Model Student of the University of Chinese Academy of Sciences
2014: Wang Yinglai Scholarship
2012: Pfizer Scholarship
2009: Outstanding Graduate of Northeast Normal University

Areas of Focus	New targets and strategies for lung cancer immunotherapy and targeted therapy Spatiotemporal evolution and intervention strategies of stem cell tumorigenesis
Publications	Loss of TSC1/TSC2 sensitizes immune checkpoint blockage in non-small-cell lung cancer, Huang Q, Li F#, Hu H, Fang Z, Gao Z, Xia G, Ng W, Khodadadi-Jamayran A, Chen T, Deng J, Zhang H, Almonte C, Labbe K, Han H, Geng K, Tang S, Freeman G, Li Y, Chen H#, Wong K#, 2022 Targeting the Atf7ip-Setdb1 complex augments anti-tumor immunity by boosting tumor immunogenicity, Hu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga L, Zeck B, Gregorio M, Dowling C, Labbe K, Deng J, Chen T, Zhang H, Zappile P, Chen Z, Ueberheide B, Karatza A, Han H, Ranieri M, Tang S, Jour G, Osman I, Sucker A, Schadendorf D, Tsirigos A, Schalper K, Velcheti V, Huang H, Jin Y, Ji H, Poirier J, Li F#, Wong KK#, 2021 Epigenetic CRISPR screens identify Npm1 as a therapeutic vulnerability in non-small cell lung cancer, Li F, Ng W, Luster T, Hu H, Sviderskiy V, Dowling C, Hollinshead K, Zouitine P, Zhang H, Huang Q, Ranieri M, Wang W, Fang Z, Chen T, Deng J, Zhao K, So H, Khodadadi-Jamayran A, Xu M, Karatza A, Pyon V, Li S, Pan Y, Labbe K, Poirier J, Miller G, Almonte C, Labbe K, Silver H, Rabin A, Jani K, Tsirigos A, Papagiannakopoulos T, Hammerman P, Possemato R, Qi J, Wong KK, 2020 In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma, Li F, Huang Q, Luster T, Hu H, Zhang H, Ng W, Khodadadi-Jamayran A, Wang W, Chen T, Deng J, Ranieri M, Fang Z, Pyon V, Dowling C, Bagdatlioglu E, Almonte C, Labbe K, Silver H, Rabin A, Jani K, Tsirigos A, Papagiannakopoulos T, Hammerman P, Velcheti V, Freeman G, Qi J, Miller G, Wong KK, 2020 Identification of TRA2B-DNAH5 gene fusion as a novel oncogenic driver in human lung squamous cell carcinoma, Li F, Fang Z, Zhang J, Li Chen, Liu H, Xia J, Zhu H, Guo C, Qin Z, Li FM, Han X, Wang Y, Feng Y, Wang Y, Zhang W, Wang Z, Jin Y, Sun Y, Wei W, Zeng R, Chen H, Ji H, 2016 LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response, Li FM, Han X, Li F, Wang R, Wang H, Gao Y, Wang X, Fang Z, Zhang W, Yao S, Tong X, Wang Y, Feng Y, Sun Y, Li Y, Wong KK, Zhai Q, Chen H, Ji H, 2015 Identification of RET gene fusion by exon array analyses in 'pan-negative' lung adenocarcinomas from never smokers, Li F, Feng Y, Fang R, Fang Z, Xia J, Han X, Liu XY, Chen H, Liu H, Ji H, 2012

Areas of Focus

New targets and strategies for lung cancer immunotherapy and targeted therapy
Spatiotemporal evolution and intervention strategies of stem cell tumorigenesis

Publications

Loss of TSC1/TSC2 sensitizes immune checkpoint blockage in non-small-cell lung cancer, Huang Q*, Li F*#, Hu H*, Fang Z, Gao Z, Xia G, Ng W, Khodadadi-Jamayran A, Chen T, Deng J, Zhang H, Almonte C, Labbe K, Han H, Geng K, Tang S, Freeman G, Li Y, Chen H#, Wong K#, 2022
Targeting the Atf7ip-Setdb1 complex augments anti-tumor immunity by boosting tumor immunogenicity, Hu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga L, Zeck B, Gregorio M, Dowling C, Labbe K, Deng J, Chen T, Zhang H, Zappile P, Chen Z, Ueberheide B, Karatza A, Han H, Ranieri M, Tang S, Jour G, Osman I, Sucker A, Schadendorf D, Tsirigos A, Schalper K, Velcheti V, Huang H, Jin Y, Ji H, Poirier J, Li F#, Wong KK#, 2021
Epigenetic CRISPR screens identify Npm1 as a therapeutic vulnerability in non-small cell lung cancer, Li F*, Ng W*, Luster T, Hu H, Sviderskiy V, Dowling C, Hollinshead K, Zouitine P, Zhang H, Huang Q, Ranieri M, Wang W, Fang Z, Chen T, Deng J, Zhao K, So H, Khodadadi-Jamayran A, Xu M, Karatza A, Pyon V, Li S, Pan Y, Labbe K, Poirier J, Miller G, Almonte C, Labbe K, Silver H, Rabin A, Jani K, Tsirigos A, Papagiannakopoulos T, Hammerman P, Possemato R, Qi J, Wong KK, 2020
In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma, Li F, Huang Q, Luster T, Hu H, Zhang H, Ng W, Khodadadi-Jamayran A, Wang W, Chen T, Deng J, Ranieri M, Fang Z, Pyon V, Dowling C, Bagdatlioglu E, Almonte C, Labbe K, Silver H, Rabin A, Jani K, Tsirigos A, Papagiannakopoulos T, Hammerman P, Velcheti V, Freeman G, Qi J, Miller G, Wong KK, 2020
Identification of TRA2B-DNAH5 gene fusion as a novel oncogenic driver in human lung squamous cell carcinoma, Li F*, Fang Z*, Zhang J*, Li Chen, Liu H, Xia J, Zhu H, Guo C, Qin Z, Li FM, Han X, Wang Y, Feng Y, Wang Y, Zhang W, Wang Z, Jin Y, Sun Y, Wei W, Zeng R, Chen H, Ji H, 2016
LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response, Li FM*, Han X*, Li F*, Wang R, Wang H, Gao Y, Wang X, Fang Z, Zhang W, Yao S, Tong X, Wang Y, Feng Y, Sun Y, Li Y, Wong KK, Zhai Q, Chen H, Ji H, 2015
Identification of RET gene fusion by exon array analyses in 'pan-negative' lung adenocarcinomas from never smokers, Li F*, Feng Y*, Fang R*, Fang Z, Xia J, Han X, Liu XY, Chen H, Liu H, Ji H, 2012

Lung Cancer Immunotherapy Targeted Therapy New Targets New Strategies Stem Cells Tumorigenesis Spatiotemporal Evolution Intervention Strategies Cancer Research

Yanhui Yin - Peking University

Desheng Xiao - Central South University

Luqing Zhao - Central South University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us